Suspended
The clinical study has stopped recruiting or enrolling participants early, but it may start again. A type of Recruitment Status.
READ MORESurrogate Measure
A variable that provides an indirect measurement of effect in situations where direct measurement of clinical effect is not feasible or practical. (Pfizer)
READ MORESub-investigator
Any individual member of the site staff who is designated and supervised by the investigator to carry out critical trial-related procedures and/or make important trial-related decisions. (Pfizer)
READ MORESubject Withdrawal
The voluntary departure of a subject from a clinical trial before the planned schedule of subject evaluations called for in the clinical trial protocol.
READ MORESubject Stipend
The Institutional Review Board (IRB) should determine that the risks to subjects are reasonable in relation to anticipated benefits [21 CFR 56.111(a)(2)] and that the consent document contains an adequate […]
READ MORESubject Eligibility Criteria
Each study’s protocol has guidelines for who can or cannot participate in the study. These guidelines, called eligibility criteria, describe characteristics that must be shared by all participants. The criteria […]
READ MORESubject
An individual who participates in a clinical study, either as a recipient of the investigational product(s) or as a control. (Pfizer)
READ MOREStudy Type
Describes the nature of a clinical study. Study types include Interventional Studies (or Clinical Trials), Observational Studies and Expanded Access. (See also Study Type data element on ClinicalTrials.gov.)
READ MOREStudy Start Date
The date that the enrollment of participants for a clinical study begins. (See also Study Start Date data element on ClinicalTrials.gov.)
READ MOREStudy Record
An entry in ClinicalTrials.gov that contains summary protocol information about a clinical study, such as recruitment status, eligibility criteria, contact information, and in some cases summary results. Each study record […]
READ MORE